TG Therapeutics IncNASDAQ:TGTX
- LAST PRICE17.9450
- TODAY'S CHANGE (%)-1.2450 (-6.4878%)
- Bid / Lots17.9300/ 8
- Ask / Lots17.9500/ 2
- Open / Previous Close19.0000 / 19.1900
- Day Range
- 52 Week Range
- Volume1,894,373
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TGTX |
|---|---|---|
| 09:32 ET | 37718 | 18.85 |
| 09:34 ET | 64457 | 18.61 |
| 09:36 ET | 18850 | 18.65 |
| 09:38 ET | 15979 | 18.58 |
| 09:39 ET | 8483 | 18.8 |
| 09:41 ET | 9374 | 18.7 |
| 09:43 ET | 17354 | 18.73 |
| 09:45 ET | 13025 | 18.75 |
| 09:48 ET | 14336 | 18.76 |
| 09:50 ET | 16626 | 18.78 |
| 09:52 ET | 19911 | 18.97 |
| 09:54 ET | 7916 | 18.86 |
| 09:56 ET | 6164 | 18.9 |
| 09:57 ET | 4555 | 18.9552 |
| 09:59 ET | 2023 | 18.93 |
| 10:01 ET | 13440 | 18.98 |
| 10:03 ET | 15435 | 18.99 |
| 10:06 ET | 17534 | 19.03 |
| 10:08 ET | 5903 | 18.99 |
| 10:10 ET | 6407 | 18.92 |
| 10:12 ET | 6382 | 18.9029 |
| 10:14 ET | 13135 | 18.8898 |
| 10:15 ET | 9645 | 18.84 |
| 10:17 ET | 5705 | 18.84 |
| 10:19 ET | 15938 | 18.76 |
| 10:21 ET | 21235 | 18.69 |
| 10:24 ET | 19110 | 18.71 |
| 10:26 ET | 6944 | 18.73 |
| 10:28 ET | 7258 | 18.73 |
| 10:30 ET | 11968 | 18.6677 |
| 10:32 ET | 6469 | 18.68 |
| 10:33 ET | 9237 | 18.64 |
| 10:35 ET | 26036 | 18.58 |
| 10:37 ET | 35693 | 18.6 |
| 10:39 ET | 1750 | 18.62 |
| 10:42 ET | 6225 | 18.6211 |
| 10:44 ET | 4023 | 18.65 |
| 10:46 ET | 9134 | 18.585 |
| 10:48 ET | 13325 | 18.6 |
| 10:50 ET | 1853 | 18.59 |
| 10:51 ET | 5459 | 18.565 |
| 10:53 ET | 26688 | 18.56 |
| 10:55 ET | 5598 | 18.595 |
| 10:57 ET | 3823 | 18.58 |
| 11:00 ET | 10738 | 18.58 |
| 11:02 ET | 2543 | 18.63 |
| 11:04 ET | 10256 | 18.6 |
| 11:06 ET | 12236 | 18.63 |
| 11:08 ET | 3456 | 18.6521 |
| 11:09 ET | 2999 | 18.63 |
| 11:11 ET | 39509 | 18.565 |
| 11:13 ET | 3183 | 18.58 |
| 11:15 ET | 4524 | 18.55 |
| 11:18 ET | 7261 | 18.59 |
| 11:20 ET | 824 | 18.6 |
| 11:22 ET | 3091 | 18.6 |
| 11:24 ET | 600 | 18.61 |
| 11:26 ET | 6507 | 18.67 |
| 11:27 ET | 6250 | 18.65 |
| 11:29 ET | 2600 | 18.625 |
| 11:31 ET | 3352 | 18.64 |
| 11:33 ET | 3163 | 18.62 |
| 11:36 ET | 24665 | 18.58 |
| 11:38 ET | 14831 | 18.575 |
| 11:40 ET | 2751 | 18.58 |
| 11:42 ET | 5096 | 18.55 |
| 11:44 ET | 9984 | 18.57 |
| 11:45 ET | 1726 | 18.58 |
| 11:47 ET | 3368 | 18.58 |
| 11:49 ET | 3684 | 18.63 |
| 11:51 ET | 5344 | 18.62 |
| 11:54 ET | 1253 | 18.64 |
| 11:56 ET | 11069 | 18.68 |
| 11:58 ET | 2627 | 18.67 |
| 12:00 ET | 2727 | 18.61 |
| 12:02 ET | 30451 | 18.65 |
| 12:03 ET | 6350 | 18.61 |
| 12:05 ET | 17423 | 18.57 |
| 12:07 ET | 2221 | 18.612 |
| 12:09 ET | 417 | 18.6 |
| 12:12 ET | 2215 | 18.5694 |
| 12:14 ET | 300 | 18.56 |
| 12:16 ET | 3330 | 18.555 |
| 12:18 ET | 16087 | 18.51 |
| 12:20 ET | 30104 | 18.37 |
| 12:21 ET | 10490 | 18.364 |
| 12:23 ET | 23612 | 18.33 |
| 12:25 ET | 12411 | 18.2989 |
| 12:27 ET | 8039 | 18.35 |
| 12:30 ET | 4132 | 18.38 |
| 12:32 ET | 1595 | 18.34 |
| 12:34 ET | 1879 | 18.36 |
| 12:36 ET | 7198 | 18.32 |
| 12:38 ET | 14574 | 18.34 |
| 12:39 ET | 6869 | 18.27 |
| 12:41 ET | 10342 | 18.27 |
| 12:43 ET | 7449 | 18.28 |
| 12:45 ET | 3324 | 18.3 |
| 12:48 ET | 3614 | 18.29 |
| 12:50 ET | 24264 | 18.21 |
| 12:52 ET | 3325 | 18.1801 |
| 12:54 ET | 7924 | 18.22 |
| 12:56 ET | 10291 | 18.22 |
| 12:57 ET | 6577 | 18.185 |
| 12:59 ET | 23816 | 18.16 |
| 01:01 ET | 6801 | 18.18 |
| 01:03 ET | 27167 | 18.14 |
| 01:06 ET | 8557 | 18.09 |
| 01:08 ET | 11887 | 18.04 |
| 01:10 ET | 54269 | 17.96 |
| 01:12 ET | 49723 | 18.03 |
| 01:14 ET | 9342 | 18 |
| 01:15 ET | 7978 | 18.03 |
| 01:17 ET | 20267 | 18.01 |
| 01:19 ET | 14677 | 18.0166 |
| 01:21 ET | 23903 | 17.93 |
| 01:24 ET | 10150 | 17.89 |
| 01:26 ET | 14896 | 17.91 |
| 01:28 ET | 4801 | 17.965 |
| 01:30 ET | 8391 | 17.95 |
| 01:32 ET | 7497 | 17.92 |
| 01:33 ET | 6401 | 17.9699 |
| 01:35 ET | 2108 | 17.94 |
| 01:37 ET | 2652 | 17.92 |
| 01:39 ET | 2112 | 17.93 |
| 01:42 ET | 8574 | 17.9201 |
| 01:44 ET | 6216 | 17.92 |
| 01:46 ET | 6230 | 17.8903 |
| 01:48 ET | 9935 | 17.92 |
| 01:50 ET | 5197 | 17.9199 |
| 01:51 ET | 4641 | 17.9499 |
| 01:53 ET | 14077 | 17.97 |
| 01:55 ET | 4477 | 17.9517 |
| 01:57 ET | 3380 | 17.97 |
| 02:00 ET | 9843 | 17.98 |
| 02:02 ET | 15275 | 17.96 |
| 02:04 ET | 15121 | 17.93 |
| 02:06 ET | 8170 | 17.89 |
| 02:08 ET | 15946 | 17.9 |
| 02:09 ET | 3200 | 17.92 |
| 02:11 ET | 2515 | 17.917 |
| 02:13 ET | 2371 | 17.92 |
| 02:15 ET | 1411 | 17.945 |
Jun 11, 2024
Jun 7, 2024
TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference, from 7:50AM ET on Friday Jun 07, 2024 by Dow Jones
7:50AM ET on Friday Jun 07, 2024 by Dow Jones
Jun 3, 2024
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference, from 7:30AM ET on Monday Jun 03, 2024 by Dow Jones
7:30AM ET on Monday Jun 03, 2024 by Dow Jones
May 31, 2024
May 28, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
TG Therapeutics Inc | 3.0B | 81.4x | --- |
Twist Bioscience Corp | 2.8B | -14.0x | --- |
MorphoSys AG | 2.7B | -5.3x | --- |
Arrowhead Pharmaceuticals Inc | 3.3B | -6.2x | --- |
ADMA Biologics Inc | 2.6B | -527.0x | --- |
Denali Therapeutics Inc | 3.2B | -22.7x | --- |
Company Information
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. TG-1701 is a novel, orally available and covalently bound Bruton’s tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in in vitro kinase screening. TG-1801 is a bispecific CD47 and CD19 antibody. It is the therapy to target both CD19, a B-cell specific market expressed across B-cell malignancies, and CD47. It also evaluates complementary products, technologies and companies for in-licensing, partnership, acquisition and/or investment opportunities.
Contact Information
- Headquarters
- 3020 Carrington Mill Blvd., Suite 475MORRISVILLE, NC, United States 27560-5435
- Phone
- 212-554-4484
- Fax
- 212-554-4531
Executives
- Chairman of the Board, President, Chief Executive Officer
- Michael Weiss
- Chief Financial Officer, Treasurer, Corporate Secretary
- Sean Power
- Lead Independent Director
- Laurence Charney
- Independent Director
- Yann Echelard
- Independent Director
- Kenneth Hoberman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.0B |
|---|---|
Revenue (TTM) | $289.3M |
Shares Outstanding | 154.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.24 |
EPS | $0.22 |
Book Value | $1.06 |
P/E Ratio | 81.4x |
Price/Sales (TTM) | 10.3 |
Price/Cash Flow (TTM) | 71.7x |
Operating Margin | 16.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
